Monitoring and evaluation (M&E) systems for advocacy interventions usually include a number of common elements. The nature of advocacy work means M&E systems need to be designed and implemented differently than in conventional projects. M&E systems for advocacy work should be simple and time efficient, and should be designed to support ongoing advocacy processes.
The #Evidence4Advocacy campaign aims at promoting evidence-based advocacy in Africa. The campaign targets CSOs, NGOs, research institutions, the private sector, advocacy think tanks, and individual consultants who… Read More »#HIV2020: Give community-led research the respect it deserves
Two years ago, the International AIDS Society (IAS) chose the United States of America (U.S.) as the site for the 2020 International AIDS Conference (AIDS2020). Community advocates argued that the U.S. was an inappropriate choice given legal travel restrictions on sex workers, people who use drugs, and Muslims, which would have made it very difficult for members of these communities to enter the country.
The #Evidence4Advocacy campaign aims at promoting evidence-based advocacy in Africa. The campaign targets CSOs, NGOs, research institutions, the private sector, advocacy think tanks, and individual consultants who in the last 10 years have been involved in advocacy research or evaluation. The campaign led by Evidence Frontiers will inform the following areas:
Every complex monitoring and evaluation (M&E) system is different, and so needs to be designed individually. Some generic steps are common to the design of most systems. Complex M&E systems need to change and evolve over time. Therefore, even once implementation has started there still needs to be a degree of ongoing design and adaptation, as well as routine support and administration.
The immediate impact of COVID-19 on African civil society organisations (CSOs) was swift, widespread and destabilizing. This is one of the main findings of the Africa CSO COVID-19 Survey that @AfricanNGOs and EPIC-Africa implemented between 28 April and 15 May 2020.
The African Academy of Sciences collaborates with Janssen to Expand Research & Development Skills and Capacity Among African Scientists
Africa lags behind the rest of the world in discovering and developing innovative medicines and vaccines for the treatment or prevention of diseases, which threaten the lives of those who live on the continent.